Fresenius Medical Care AG & Co. (ADR)  

(Public, NYSE:FMS)   Watch this stock  
Find more results for FMS
+0.31 (0.75%)
Mar 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 41.71 - 42.07
52 week 31.28 - 42.85
Open 41.73
Vol / Avg. 0.00/161,726.00
Mkt cap 25.93B
P/E 24.31
Div/yield 0.53/1.26
EPS 1.72
Shares 303.18M
Beta 0.49
Inst. own 4%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 9.32% 7.96%
Operating margin 15.36% 14.24%
EBITD margin - 18.50%
Return on average assets 6.50% 5.19%
Return on average equity 14.21% 11.19%
Employees 99,895 -
CDP Score - 82 D


Else-Kroener-Strasse 1
+49-6172-6090 (Phone)
+49-6172-6092301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Fresenius Medical Care AG & Co KGaA is a Germany-based kidney dialysis company that operates in the fields of dialysis care and dialysis products for the treatment of end-stage renal disease (ESRD). Its dialysis business is vertically integrated and offers products and services for the entire dialysis value chain, providing dialysis treatment at dialysis clinics it owns or operates and supplying these clinics with a range of products. The Company offers two types of dialysis treatment: Hemodialysis (HD), where the machine controls the blood from the patient through a special filter, the dialyzer, and Peritoneal Dialysis (PD), where the patient�s peritoneum is used as a dialyzing membrane. Its dialysis product portfolio includes chronic hemodialysis, home dialysis, renal pharmaceuticals, acute therapy, liver support, therapeutic apheresis, therapy support and water technology, among others. In addition, the Company sells dialysis products to other dialysis service providers.

Officers and directors

Gerd Krick Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Rice Powell Chairman of the Management Board, Chief Executive Officer
Bio & Compensation  - Reuters
Dieter Schenk Vice Chairman of the Supervisory Board
Bio & Compensation  - Reuters
Michael Brosnan Chief Financial Officer, Member of the Management Board
Bio & Compensation  - Reuters
Oliver Maier Senior Vice President of Investor Relations
Bio & Compensation  - Reuters
Roberto Fuste Member of the Management Board for Asia-Pacific
Bio & Compensation  - Reuters
Ronald Kuerbitz Member of the Management Board for North America
Bio & Compensation  - Reuters
Olaf Schermeier Member of the Management Board for Global Research & Development
Bio & Compensation  - Reuters
Kent Wanzek Member of the Management Board, Global Products Manufacturing Operations
Bio & Compensation  - Reuters
Dominik Wehner Member of the Management Board for Europe, Middle East and Africa
Bio & Compensation  - Reuters